Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
JAMA Network Open|April 28, 2025
Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income CountriesLinsey Eldridge, Nina R Goodman, Amina Chtourou, et al.
Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
The Lancet Regional Health. Europe|August 13, 2025
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer AssociationManon Allaire, Leonardo G Da Fonseca, Marco Sanduzzi-Zamparelli, et al.
Journal of the National Cancer Institute|July 2, 2025
A summary of the national cancer institute think tank on advancing gastric cancer preventionM Constanza Camargo, Christian C Abnet, Jeremy L Davis, et al.
Cell Reports. Medicine|January 27, 2024
Lineage and ecology define liver tumor evolution in response to treatmentMahler Revsine, Limin Wang, Marshonna Forgues, et al.
La Radiologia Medica|December 10, 2024
Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapyLaetitia Saccenti, Nicole Varble, Tabea Borde, et al.
JCO Global Oncology|April 23, 2026
Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative CountriesMarisa Nishio, Hiromi Sugiyama, Valerie McCormack, et al.
The Oncologist|March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract CarcinomaCecilia Monge, Erica C Pehrsson, Changqing Xie, et al.
Cancer Medicine|January 11, 2024
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinomaCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Plos One|November 11, 2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinomaEsther Mena, Joanna Shih, Joon-Yong Chung, et al.
Pageof 5